Clinical outcomes 96 The researchers had concluded that, Men had higher risks of cardiac death (3.7% v/s 1.6%) and MACE (8.4% v/s 4.7%) at five years when they compared with women. It was also noted that, non fatal MI and TLR were similar between Men and Women (5).
Part and co-workers conducted the study, which evaluated the long term outcomes of PCI and CABG in diabetic and non diabetic patient pool. After the 2 years of follow up, death by either cardiac or non cardiac reason is 12.6% and 16.5%, composite outcome as 14.9% and 19.9% and repeat revascularization was 19% and 4.6% in PCI and CABG group respectively, in Diabetic population. Whereas, in non diabetic population, death-8.1%
and 10.4%, composite outcome -10.1% and 13.6% and repeat revascularization was 16 .6% and 5.4% in PCI and CABG group respectively (6) .
In a 5 year follow up study (7) , multicenter registry of 4338 CAD patients has concluded that, MACEs of PCI group (41.8%) and CABG group (29.2%) which is significant(p<0.001). The odds ratio for mortality comparing CABG to PCI was 0.69, whereas odds ratio for any MACE was 0.58 (p<0.001).
In a study conducted at Poland, researchers evaluated the BMS and DES in STEMI patients for their clinical outcomes. Mortality rate in DES group (8.9%) was observed v/s BMS group (15.5%). Lower incidences of both death and MI were observed in PCI group (9.5% v/s 16%). Combined endpoint of death, MI and TVR (19.3% v/s 31.3%, p<0.001) was recorded in favour of DES (8) .
In the recently published New England Journal of Medicine, Armstrong and his coworkers (9) evaluated the clinical outcomes in STEMI patients after fibrinolysis or primary PCI. Composite of death from any cause, shock, congestive heart failure or MI are occurred in 12.4% patients in fibrinolysis group (relative risk 0.86;95% confidence interval, p=0.21) and 14.3% in primary PCI group. More intracranial haemorrhages occurred in fibrinolysis group (1%) compared with PCI group (0.2%).
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The study presented the data from Zwolle -6 trial emphasized the co-morbid condition of diabetes mellitus and compared the results between PCI v/s Balloon angioplasty. After One year of the follow up, Death occurs in 10.7% patients of stent group, whereas, 9.2% patients in balloon angioplasty group. Death and or repeat MI was 14.3% and 11.8% for stent and balloon angioplasty group respectively. 21.4% and 18.4% patients had TVR in stenting and balloon angioplasty group respectively (10).
Lipid profile
NCEP adult treatment plan III guidelines (11) Hence, we can conclude that, even the changes were occurred at CG which is due to drugs, which the participants were consumed. However, the changes were more prominent in IG, which is due to along with drugs; pharmaceutical care was provided by RP.
In a RCT (12) , where pharmaceutical care was provided to IG for the patients of dyslipidemia patients, the change in total cholesterol values (17.7 mg/dl) are significant when compared to CG (7.4 mg/dl) and change in LDL values in IG (23.4 mg/dl) was significantly higher compared to CG (12.8 mg/dl). This emphasizes the role of pharmaceutical care in dyslipidemia patients.
In a study similar to our study, where 30 patients were provided the pharmaceutical care after cardiac surgery found that, lipid profile results were achieved the significant (p<0.05) at 2 years of follow up (13) .
In a study conducted by Lee and co-workers found that, PC for the elderly patients had no significant changes in LDL values between IG and CG (14) . In a systematic review done by Charrois et al., which evaluated the pharmaceutical care of dyslipidemia patients in 21 studies reveals that, mean LDL levels were 10.7 mg/dl lower when compared to standard care group and mean TC levels are significantly lower than usual standard care groups (18) .
Our present study also shows that, in IG -mean Total Cholesterol values were 19.98 mg/dl lesser than CG, mean HDL values were 1.52 mg/dl greater than CG and mean LDL values were 10.43 mg/dl lesser than CG. This signifies that, our study yielded the similar results in the management of dyslipidemia across the globe.
Fasting blood sugar
We 
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In the IG, where pharmaceutical care was provided for the participants, had shown the significant amount of reduction 10.26 mg/dl in the FBS values were observed compared to CG. These results were tabulated in table 17 and represented graphically in figure 18 .
In a RCT involving diabetes patients in Jordan (19) , Pharmaceutical care provided to the patients in IG had achieved the better fasting blood glucose levels (-2.3 millimoles/L) comparatively to CG patients (+0.9 millimoles/L), who received the standard care. 
Drug related problems
RP identified and resolved drug related problems in the intervention group of patients.
135 drug related problems were identified which were of drug -drug interactions (104) major category. Clopidogrel and Pantaprazole were given in discharge prescription, which was resolved by counselling the patient to take pantaprazole in the early morning in empty stomach and to take Clopidogrel after breakfast with a time gap of 2 hours.
Other discrepancies like, dose adjustments (15) were done with the consultation with cardiologist. During the discharge prescription-missing of adding diabetic drug (9) , beta blocker (4) and ACE inhibitor (3).
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RP identified 12 cases of Amlodipine induced pedal edema in the IG patients and reported to cardiologist, prompted to change into Cilindipine which is successfully reduces the edema. This initiation by RP has led to research on this parameter and resulted in a publication in North American Journal of Medical Sciences.
Body mass index
We calculated Body Mass Index (BMI) of the participants at baseline and at 12 months for both the groups. These results were tabulated in table 18 
Pill count score
We calculated the pill count score at first follow up and also at 2 nd , 3 rd and 4 th follow ups i.e. at 12 months. Pill count score > 80% of their prescribed dose was considered as adherent to the therapy. The results were tabulated in table 16 and depicted in the figure   17 . At first follow up, mean pill count score for CG was 72.08 ± 6.28% and 89.04 ± 7.20% in IG. It is quite interesting to know that, at 2 nd follow up-there is a increasing trend of medication adherence in-terms of pill count score in CG , where as there is a decline in the pill count score in the IG. However, this trend is not observed during further follow up. It was worthy to observe that, after 6 months of the therapy, medication adherence is almost stabilized which is evident by pill count score. At the end of study period, mean pill count scores were 73.03 ± 5.32% and 85.09 ± 4.75% for CG and IG respectively. At the end of study period, 6 participants (6.25% of CG population)
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102 were adherent to medications in CG compared to 95 participants (93% of IG population) in IG. Upon performing chi square test; it was found statistically significant (p<0.001).
On performing repeated measures ANOVA test, we found that there is a significant difference between the IG and CG favouring the participants in IG are more adherent to the therapy (p<0.001) throughout the study period.
In a RCT conducted by Lee (14) and colleagues, pharmaceutical care program had improved medication adherence increased to 96% population in the IG compared to 69%
in CG, which is highly significant(p<0.001) and is associated with significant reductions in the systolic BP.
In a RCT conducted at Denmark involving the elderly patients with poly pharmacy, PC was provided to IG at home compared to standard care as CG. Patients were similarly non adherent at 11% and 10% for IG and CG respectively (22) .
In a non blinded RCT study conducted by Silveiera (23) (27) .
In a systematic review of RCT concludes that, simplifying the dosage regimen increases the adherence rates from 8% to 19.6% across the studies of interest. Complex interventions like pharmaceutical care increased the adherence rates up to 41% in the study population (28).
Conclusion
In the present study, as the medication adherence increases in the IG, it also decreases the Total cholesterol level, LDL level and Triglyceride levels and increases the HDL level.
Fasting blood sugar levels are reduced in the study population. Body mass Index also decreased significantly (p<0.001) in the IG study population compared to CG.
Major adverse cardiac events and hospital re admission rates were similar in both the groups which are not significant between the groups.
Hence, we can conclude that, pharmaceutical care provides the holistic approach to manage the lipid profile, fasting blood sugar and body mass index which is highly significant in the patients who underwent angioplasty procedure.
